Physician profile
Johnny Young
NPI 1508830340
$3,010.50
in general payments reported to CMS, 2019-2025
13 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $223 · 2021: $65.17 · 2022: $131 · 2023: $1,453 · 2024: $848 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,709 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,709.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Education | $276.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galt Pharmaceuticals, LLC | $1,452.88 | 2023 | Orphengesic Forte, Oravig |
| Atland Pharmaceuticals, LLC | $616.41 | 2024-2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Astellas Pharma US INC | $411.44 | 2022-2025 | Veozah |
| Abbvie INC. | $157.65 | 2019-2021 | |
| Amgen INC. | $108.49 | 2019-2020 | |
| Ethicon US, LLC | $97.79 | 2021-2024 | Surgiflo Hemostatic Matrix |
| Monaghan Medical Corporation | $32.80 | 2024 | Aeroeclipse |
| Mylan Pharmaceuticals INC. | $30.99 | 2020-2021 | |
| Lupin INC. | $27.46 | 2019 | |
| Pfizer INC. | $25.76 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.08 | 2020 | |
| Radius Health, INC. | $15.60 | 2021 | |
| Hologic Sales and Service, LLC | $14.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.